Mesalazine 800 mg tablets (Asacol): Supply issue

Supply issue Active

Chiesi, the supplier, has reported a supply constraint of 800 mg Asacol tabs from late February until July 2024.

18 July 2024 update

Chiesi advises it has stock of the 400 mg on hand. Stock is being allocated to wholesalers on a weekly basis to ensure equitable supply, a shipment has just been released. However it may take 1 to 2 weeks to move through the supply chain to pharmacies.

A delivery of 400 mg and 800 mg tablets is due late-July, we will provide more information once the supplier has confirmed the arrival date.

Affected product

Chiesi, the supplier, has reported a supply constraint of 800 mg Asacol tabs from late February until July 2024.

  • Chemical: Mesalazine
  • Brand: Asacol
  • Pharmacode: 2470616 and 2536552
  • Subsidy: $85.50
  • Measure / Qty: per 90

Schedule listing for mesalazine(external link)

This supply constraint primarily affects the 800 mg tablet of mesalazine. Other presentations remain available.

Alternative products

We have received clinical advice that people can take two 400 mg tablets of mesalazine. 

Supplier now out of stock of section 29 alternative 

To ensure a product remains available, Chiesi brought in Australian-branded Asacol. While the packaging is similar, it will still need to be prescribed and supplied as an unapproved medicine.

Chiesi letter to prescribers about the alternative product [PDF, 106 KB]

It was listed from 1 April 2024.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.  

Sign up to our email list for regular emails about supply issues and more(external link)